Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report

Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report

Abstract Background Pseudoprogression refers to a specific pattern of response sometimes observed in malignant melanoma patients receiving treatment with immune-checkpoint inhibitors. Although cases with pseudoprogression documented once have been reported previously, there have been no case reports...

Full description

Bibliographic Details
Main Authors: Yukinori Ozaki, Junichi Shindoh, Yuji Miura, Hiromichi Nakajima, Ryosuke Oki, Miyuki Uchiyama, Jun Masuda, Keiichi Kinowaki, Chihiro Kondoh, Yuko Tanabe, Tsuyoshi Tanaka, Shusuke Haruta, Masaki Ueno, Shigehisa Kitano, Takeshi Fujii, Harushi Udagawa, Toshimi Takano
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Cancer
Subjects:
Esophageal malignant melanoma
Nivolumab
Pseudoprogression
Serial
Online Access:http://link.springer.com/article/10.1186/s12885-017-3785-4

Internet

http://link.springer.com/article/10.1186/s12885-017-3785-4

Similar Items